ABOUT

From Singapore for the world

Our Purpose

We deliver early, actionable and personalised diagnoses across the care continuum to improve and save lives.

We discover, develop, and deliver accurate preventive healthcare solutions for cancer, cardiovascular, metabolic and infectious diseases, and make them accessible to all.

Our Values

Can-Do Attitude

Solving challenges for our customers and colleagues is our top priority.

We are determined to take action and achieve results.

Integrity

We are trustworthy and reliable.

We deliver on our promise.

Agility

We are dynamic and adaptable in a rapidly-changing world.

Curiosity

Learning and growing together as a team helps us achieve our goals.

We are open-minded and innovative.

Empathy

Mutual respect and understanding are the foundation of our relationships.

We are inclusive and collaborative.

Our Story

We are a Singapore-headquartered biotechnology company focused on improving and saving lives with RNA-powered disease early detection tests.

Our story began in early 2000 when our founders pioneered a highly sensitive, specific and robust detection technology for microRNA (miRNA), the smallest genetic material ever found in human and other living organisms. Realizing the potential of miRNA-based clinical applications in solving unmet needs in cancer, cardiovascular, metabolic, and infectious diseases, we decided to bring our technology from lab to clinic.

In 2014, we spun off from Agency of Science, Technology and Research (A*STAR) to commercialise our technology and develop accurate multi-cancer early detection solutions and make them readily available and accessible to people who need them.

We believe that the future of healthcare will shift from treating the sick to preventive healthcare. Our science and innovation will continue as we are committed to changing lives by delivering preventive healthcare solutions for all.

We are a Singapore-headquartered biotechnology company focused on improving and saving lives with RNA-powered disease early detection tests.

Our story began in early 2000s when our founders pioneered a highly sensitive, specific and robust detection technology for microRNA (miRNA), the smallest genetic material ever found in human and other living organisms. Realizing the potential of miRNA-based clinical applications in solving unmet needs in cancer, cardiovascular, metabolic, and infectious diseases, we decided to bring our technology from lab to clinic.

In 2014, we spun off from Agency of Science, Technology and Research (A*STAR) to commercialise our technology and develop accurate multi-cancer early detection solutions and make them readily available and accessible to people who need them.

We believe that the future of healthcare will shift from treating the sick to preventive healthcare. Our science and innovation will continue as we are committed to changing lives by delivering preventive healthcare solutions to all.

Our Milestones

Our Awards

Copyright © 2022 MiRXES Pte Ltd. All rights reserved. | Privacy Policy
Scroll to Top